Keyword: Bayer

News

Germany Moves Toward Glyphosate Phase-out

06.09.2019 - In a compromise agreement presented this week, Germany’s federal cabinet voted to curb the use of the controversial chemical glyphosate up to 2023, active ingredient in the equally...

News

Bayer to Sell Animal Health to Elanco

21.08.2019 - As widely expected, Bayer has definitively agreed to sell its animal health business to Eli Lilly spinoff Elanco Animal Health. The $7.6 billion deal will create the market’s...

News

Syngenta-funded paper Says Glyphosate Best at Dawn

20.08.2019 - With the debate over the possible carcinogenity of Monsanto’s (now Bayer’s) Roundup herbicide continuing to rage, a peer-reviewed research paper partly funded by Swiss...

News

Bayer Ready to Wind up Glyphosate Suits?

12.08.2019 - As the number of lawsuits from people claiming that Monsanto’s Roundup herbicide caused their cancer mount – to currently more than 18,000 –signals increasingly point to an out-of...

News

Bayer Buys Cell Therapy Specialist BlueRock

09.08.2019 - Bayer has announced it will pay for $240 million upfront to acquire all of BluerockTherapeutics, a privately held US-headquartered biotech in which it currently holds more than 40%...

News

Bayer and Lanxess Divest Currenta Stakes

07.08.2019 - In separate transactions still subject to approval by regulatory authorities, Bayer and Lanxess have sold their respective 60% and 40% stakes in German infrastructure company...

News

Bayer Faces 5,000 new Roundup Lawsuits

31.07.2019 - Cancer sufferers in the US seem to be filing new lawsuits that charge they were harmed by Monsanto’s glyphosate-based Roundup herbicide faster than current franchise owner Bayer...

News

Damages Reduced in Third Roundup Verdict

29.07.2019 - A third judge has slashed a jury’s damage award to a plaintiff in a lawsuit involving Monsanto’s glyphosate-based Roundup herbicide. The award reduced last week by Judge Winifred...